Roche Inks RNA-Targeted Small Molecule Pact With Ribometrix

Deal snapshot: Roche’s third partnership around small molecule, RNA-targeted therapies taps Ribometrix’s three-dimensional structural analysis of RNA to find pockets amenable to small molecule drugs.

Business partners hands on top of each other symbolizing companionship
Deal with Ribometrix is third for Roche in RNA-targeting small molecule R&D

Who: Roche/Ribometrix

What: Roche’s Genentech subsidiary and Ribometrix will team up to discover and develop small molecule drug candidates that can modify...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

More from Business